Identification of a cut‐off for the macis score to predict the prognosis of differentiated thyroid carcinoma in children and young adults

The metastases, age at diagnosis, completeness of resection, invasion, size of the tumor (MACIS) scoring system was developed to predict disease‐specific survival in patients with differentiated thyroid carcinoma (DTC), mainly for adults, with a cut‐off score of 6. The purpose of this study was to evaluate its ability to predict prognosis of DTC in children and young adults.

[1]  K. Lorenz,et al.  Papillary thyroid cancer in children and adolescents does not differ in growth pattern and metastatic behavior. , 2010, The Journal of pediatrics.

[2]  M. Phillip,et al.  Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. , 2009, The Journal of pediatrics.

[3]  M. Gondwe The National Cancer Centre , 2008 .

[4]  S. Rivkees,et al.  Differentiated thyroid cancer in children: diagnosis and management , 2008, Current opinion in oncology.

[5]  M. Çamlibel,et al.  Prognostic factors determining survival in differentiated thyroid cancer , 2007, Journal of surgical oncology.

[6]  D. Mankoff,et al.  Differentiated pediatric thyroid cancer: correlates with adult disease, controversies in treatment. , 2007, Seminars in nuclear medicine.

[7]  B. Lang,et al.  Staging Systems for Papillary Thyroid Carcinoma: A Review and Comparison , 2007, Annals of surgery.

[8]  A. Ferrari,et al.  Papillary Carcinoma of the Thyroid Gland of Childhood and Adolescence: Morphologic Subtypes, Biologic Behavior and Prognosis: A Clinicopathologic Study of 42 Sporadic Cases Treated at a Single Institution During a 30-Year Period , 2006, The American journal of surgical pathology.

[9]  C. Larsson,et al.  Predictors of outcome in patients with papillary thyroid carcinoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  S. Todo,et al.  Management of childhood and adolescent thyroid carcinoma: long-term follow-up and clinical characteristics. , 2006, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[11]  M. Charron,et al.  Evidence-based Review of Treatment and Follow up of Pediatric Patients with Differentiated Thyroid Carcinoma , 2006, Journal of pediatric endocrinology & metabolism : JPEM.

[12]  N. Bhattacharyya,et al.  Population‐Based Outcomes for Pediatric Thyroid Carcinoma , 2005, The Laryngoscope.

[13]  J. Wu,et al.  Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. , 2004, Thyroid : official journal of the American Thyroid Association.

[14]  R. Tuttle,et al.  The MACIS Score Predicts the Clinical Course of Papillary Thyroid Carcinoma in Children and Adolescents , 2004, Journal of pediatric endocrinology & metabolism : JPEM.

[15]  C. Reiners,et al.  Differentiated thyroid cancer in childhood: pathology, diagnosis, therapy. , 2003, Pediatric endocrinology reviews : PER.

[16]  P. Hall,et al.  Second primary malignancies in thyroid cancer patients , 2003, British Journal of Cancer.

[17]  D. Robie,et al.  Tumor Size and Extent of Disease at Diagnosis Predict the Response to Initial Therapy for Papillary Thyroid Carcinoma in Children and Adolescents , 2003, Journal of pediatric endocrinology & metabolism : JPEM.

[18]  P. Grigsby,et al.  Childhood and adolescent thyroid carcinoma , 2002, Cancer.

[19]  D. Farley,et al.  Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. , 2000, Surgery.

[20]  C. Sklar,et al.  Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. , 2000, Journal of pediatric surgery.

[21]  L. Ries,et al.  Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. , 1999 .

[22]  Michael R. Tuttle,et al.  Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults , 1998, Clinical endocrinology.

[23]  M. Dottorini,et al.  Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  E. Bergstralh,et al.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.

[25]  D. van Nostrand,et al.  Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  C. Edmonds,et al.  The long-term hazards of the treatment of thyroid cancer with radioiodine. , 1986, The British journal of radiology.